The Ganesha Lab

From LATAM to the world: biotech without borders 🌎 Some of the most inspiring biotech journeys begin in Latin America and go on to make a global impact. At Biohunt Summit 2025, we’ll showcase these stories in the panel: “Born in LATAM, Built for the World: Startups Going Global". Featuring visionary panelists: • Alberto Rodriguez-Navarro, MD FACS – Founder & CEO, Levita Magnetics • Diego Ibañez Peña – CFO, Botanical Solution • Eduardo Abeliuk – Founder & CEO, TeselaGen Biotechnology These leaders are proving that biotech innovation has no borders, turning science from the region into solutions for the world. 📅 October 28, 2025 📍 Rubell Museum, Miami Join investors, industry experts, and global biotech leaders at the most relevant summit for LATAM innovation. Register now: https://luma.com/6mvypypm #BiohuntSummit2025 #Biotech #Startups #Investors #TheGaneshaLab #VentureCapital

Big news from our alumni: Eywa Biotech has raised USD 2.5 million to expand their impact in mental health innovation! ✨ A proud moment for Eywa, graduate of our BIGinBIO program, as they close a major round led by Draper Associates, with participation from Draper Cygnus, Panambí Ventures, and GRIDX. This funding will enable them to advance their clinical-grade psychedelic platform, scale globally, and solidify their position as a leader in mental health biotech. We’re also excited to share that Eywa will join us at the Biohunt Summit 2025 in #Miami, connecting with investors and global biotech leaders. Congratulations to the team! A true example of how Latin American science can make a global impact. #BIGinBIO #TheGaneshaLab #BiohuntSummit2025 #Biotech #Startups

We just led the $2.5M seed round of Eywa Biotech, the first company in Latin America producing pharmaceutical-grade psychedelic compounds through biosynthesis. When I first met Victoria Costa Paz, she told me her goal was simple but audacious: to reinvent the future of mental health, to make it safe, accessible, sustainable, and built on real science. At just 28, she’s done something no one in Latin America has before. Eywa is scaling the biosynthesis of psychedelic compounds like psilocybin, the active ingredient now being studied globally for depression, PTSD, and anxiety. Even in the USA, the FDA has already granted a psilocybin analog compound "breakthrough therapy" status as an adjunctive treatment for major depressive disorder, recognizing that early data is too promising to ignore. While it’s not yet approved, this designation is accelerating research worldwide and opening the door to a new era of mental health treatments. Instead of relying on slow, resource-intensive extraction, Eywa uses synthetic biology to produce these molecules faster, cleaner, and at a fraction of the cost, all under GMP standards. What Victoria and her team are building is more than a company. It is a signal. That world-class biotech can come from anywhere. That women-led science deserves conviction capital. And that Latin America can lead in deep tech and mental health innovation. The science is already happening... → Psychedelic compounds, sustainably produced → Clinical-grade quality, globally scalable → Accessible treatments for millions We’re proud to lead Eywa’s $2.5M seed round alongside Draper Cygnus, GRIDX, and Panambí Ventures, and to support Victoria and her team as they build a new foundation for mental health, sustainably and at scale. The future of mental health will be built by the founders bold enough to reimagine it.

At the Deep Tech Summit in São Paulo by EMERGE Brasil, our Portfolio Manager, Matias Rothhammer, shared insights on go-to-market strategies for science-based companies with an audience of over 120 people. The event was also a chance to: ✅ Connect our startups with investors, corporates, and peers in Brazil. ✅ Build new partnerships with leading players like Bayer, Corteva, Thermo Fisher Scientific and more. ✅ Strengthen ties with institutions such as Sebrae Startups, Finep, and FAPESP. Brazil’s ecosystem showed strong interest in our portfolio, and we are excited to support these connections moving forward! #DeepTech #Biotech #Latam #TheGaneshaLab

During the Deep Tech Summit in São Paulo, organized by EMERGE Brasil, our founder, Markus Schreyer, participated in a panel on the future of deep tech investment. Key takeaways: 🔹 LATAM’s deeptech ecosystem is growing rapidly: 60% aligns with The Ganesha Lab’s thesis. 🔹 With 40% of global biodiversity, the region has a unique chance to create a global biotech impact. 🔹 To attract international capital, startups must adopt a global mindset from the start. We’re proud to be part of these conversations and to continue building bridges between Latin America, investors, and global markets. #DeepTech #Biotech #Investors #Latam #TheGaneshaLab

Big news for biotech in Latin America! 🚨 At the Deep Tech Summit in São Paulo, organized by our partner EMERGE Brasil, we announced together with Life Science Nation the launch of a biotech accelerator hub in São Paulo by 2025. This hub will be a two-way bridge: helping Latin American startups scale globally and bringing international investors and technologies into the region. We’ll be sharing more at #BiohuntSummit2025 in #Miami: 📍 Rubell Museum, October 28   🔥 Fireside chat with Markus Schreyer (TGL) & Dennis Ford (LSN)   🌎 Biotech startups pitching to global investors It is a registration-only event! Register now as an investor or industry expert: https://luma.com/6mvypypm Read more about this milestone: https://lnkd.in/ezwfmEAV #Biotech #LifeSciences #LatinAmerica #Innovation #SaoPaulo Matt Stanton Camilo Andrés Anabalón Alamos Matias Rothhammer Monica A Lopez Pinochet

Final call 🚨! Applications close on September 30 for the Go USA Connect 2025, our softlanding program in #Miami. Don't miss out on the opportunity of: 💡 Virtual training + 5 days in Miami 💡 1:1 mentoring and pitch coaching directly from experts. 💡 Deliver a VIP pitch at the Biohunt Summit (https://lnkd.in/ejx-XdTY) at the iconic Rubell Museum, presenting directly to top investors and industry leaders. 👉 Send your one-pager and secure your spot today: https://lnkd.in/evmkyy9M #Biotech #Startups #Softlanding #Miami #BiohuntSummit2025

From Biohunt Summit #Miami to the world, Bifidice s.p.a. has shown what it means to transform science into good business. Led by Anastasia Gutkevich, PhD, the company took its probiotic ice cream from an innovative idea to a growing international venture, securing funding, entering major retail channels, and expanding. 🍦 This journey embodies the spirit of Biohunt Summit 2025: connecting visionary startups with the right investors and partners to scale real impact. 🔴 Join us in Miami this October 28 at the Rubell Museum to meet the next generation of biotech game-changers. Assist as an investor or industry expert: https://luma.com/6mvypypm 😉 #BiohuntSummit2025 #Biotech #Innovation #FoodTech